Preemptive Analgesia with Nonsteroidal Anti-Inflammatory Drugs in the Perioperative Period

Objective. A comparative assessment of the efficacy and safety of the preemptive use of ibuprofen and ketoprofen in patients undergoing elective surgery under general anesthesia.

Material and methods. A multicenter randomized prospective study included 58 patients grouped into 2 arms. Ibuprofen 800 mg in Group 1 (N=32), and ketoprofen 100 mg in Group 2 (N=26) were administered intravenously 30 minutes prior to surgical procedure, and afterwards every 12 hours during patient’s stay in the intensive care unit. Efficacy and safety were assessed using a visual analog scale (VAS), patient’s need in opioid analgesics, laboratory parameters (serum levels of cortisol, cystatin C, CBC, coagulogram, TEG) and instrumental methods (algesimetry — qNOX).

Results. VAS values were 32.4% lower in Group 1 vs Group 2 in the immediate postoperative period, P=0.003. By the end of Day 1 this difference was no longer visible following the use of promedol. There was a correlation between qNOX values at the end of surgery and VAS values at patient’s waking up from anesthesia (P=0.0007). Cortisol plasma concentrations in groups 1 and 2 did not differ significantly, P=0.105. The average daily promedol consumption in Groups 1 and 2 was 42±17.5 mg/day and 50±19.7 mg/day, respectively, P=0.022. Cystatin C concentrations in the first morning after surgery was 0.95±0.29 mg/l in the ibuprofen group, and 1.19±0.43 mg/l — in the ketoprofen group, P=0.027. Signs of renal dysfunction were documented in 4 out of 32 patients (12, 5%) from Group 1, and in 10 of 26 (38.5%) patients from Group 2 since the end of surgery and up to the first postop morning, the Chi-squared value was 0.031. Hemostasis was not affected by NSAIDs use in both groups.

Conclusion. Ibuprofen provided more powerful analgesia, than ketoprofen in the postoperative period, while during surgical procedure both drugs showed similar anlgesic efficacy. Patients on ibuprofen required significantly fewer additional boluses of opioid analgesics. Both drugs showed no clinically significant effect on hemostasis and hematopoiesis. More rare occurrence of renal dysfunction in Group 1 patients is indicative of lower nephrotoxicity of ibuprofen.

1. Taylor K. O. Morbidity associated with axillary surgery for breast cancer. ANZ J Surg. 2004; 74 (5): 314–317. DOI: 10.1111/j.1445-1433.2004.02992.x. PMID: 15144248.

2. Bradley N., Davis L., Chow E. Symptom distress in patients attending an outpatient palliative radiotherapy clinic. J Pain Symptom Manage. 2005; 30 (2): 123–131. DOI: 10.1016/j.jpainsymman.2005.02.015. PMID: 16125027.

3. Di Maio M., Gridelli C., Gallo C., Manzione L., Brancaccio L., Barbera S., Robbiati S. F., et al. Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer. 2004; 90 (12): 2288–2296. DOI: 10.1038/sj.bjc.6601810. PMID: 15162156.

4. Hwang S. S., Chang V. T., Cogswell J., Morales M., Srinivas S., Kasimis B. Study of unmet needs in symptomatic veterans with advanced cancer: incidence, independent predictors and unmet needs outcome model. J Pain Symptom Manage. 2004; 28 (5): 421–432. DOI: 10.1016/j.jpainsymman.2004.02.023.

5. van den Beuken-van Everdingen M. H. J., Hochstenbach L. M. J., Joosten E. A. J., Tjan- Heijnen V. C. G., Janssen D. J. A. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016; 51 (6): 1070–1090.e9. DOI: 10.1016/j.jpainsymman.2015.12.340. PMID: 27112310.

6. Kroenke K., Theobald D., Wu J., Loza J. K., Carpenter J. S., Tu W. The association of depression and pain with health- related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage. 2010; 40 (3): 327–341. DOI: 10.1016/j.jpainsymman.2009.12.023. PMID: 20580201.

7. Porter L. S., Keeffe F. J. Psychosocial issues in cancer pain. Curr Pain Headache Rep. 2011; 15 (4): 263–270. DOI: 10.1007/s11916-011-0190-6. PMID: 21400251.

8. Rief W., Bardwell W. A., Dimsdale J. E., Natarajan L., Flatt S. W., Pierce J. P. Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat. 2011; 130 (2): 579–586. DOI: 10.1007/s10549-011-1614-z. PMID: 21656272.

9. He Q.-H., Liu Q.-L., Li Z., Li K.-Z., Xie Y.-G. Impact of epidural analgesia on quality of life and pain in advanced cancer patients. Pain Manag Nurs. 2015; 16 (3): 307–313. DOI: 10.1016/j.pmn.2014.08.003. PMID: 25439118.

10. Ovayolu N., Ovayolu Ö., Serçe S., Tuna D., Çöçelli L. P., Sevinç A. Pain and quality of life in Turkish cancer patients. Nurs Health Sci. 2013; 15 (4): 437–443. DOI: 10.1111/nhs.12047. PMID: 23480371.

11. Oliveira K. G. von Zeidler S. V., Podestá J. R., Sena A., Souza E. D., Lenzi J., Bissoli N. S., et al. Influence of pain severity on the quality of life in patients with head and neck cancer before antineoplastic therapy. BMC Cancer. 2014; 14: 39. DOI: 10.1186/1471-2407-14-39. PMID: 24460780

12. Bona L. G., Geleta D., Dulla D., Deribe B., Ayalew M., Ababi G., Bogale N., et al. Economic burden of cancer on cancer patients treated at Hawassa university comprehensive specialized hospital. Cancer Control. 2021; 28: 107327482110092. DOI: 10.1177/10732748211009252. PMID: 33858225.

13. Chronic pain syndrome (CPS) in adult patients in need of palliative care. Clinical recommendations. 2016. (in Russ.)]. Hronicheskij-bolevoj-sindrom-HBS-u-vzroslyh-1.pdf (pro-palliativ.ru)

14. Popov A. S., Ekstrem A. V., Kazantsev D. A. Personalized therapy of postoperative pain: Monograph. Volgograd State Medical University. 2019. (in Russ.). ISBN 978-5-9652-0554-7.

15. Aurilio C., Pace M. C., Sansone P., Giaccari L. G., Coppolino F., Pota V., Barbarisi M. Multimodal analgesia in neurosurgery: a narrative review. Postgrad Med. 2022; 134 (3): 267–276. DOI: 10.1080/00325481.2021.2015221. PMID: 34872428.

16. Ochroch E. A., Mardini I. A., Gottschalk A. What is the role of NSAIDs in pre-emptive analgesia? Drugs. 2003; 63 (24): 2709–2723. DOI: 10.2165/00003495-200363240-00002. PMID: 14664651.

17. Silva P. U. J., Meneses- Santos D., de Andrade Vieira W., Ramacciato J., da Silva R. P., Silva M. C.P., Rode S. M., et al. Preemptive use of intravenous ibuprofen to reduce postoperative pain after lower third molar surgery: a systematic review of randomized controlled trials. Clinics. 2021; 76 (1): e2780. DOI: 10.6061/clinics/2021/e2780.

18. Kislitsyn A. A. Pre-emptive analgesia in endodontic practice. Sustainable Development of Science and Education/Ustoichivoe Razvitie Nauki i Obrazovaniya. 2019; 4: 452–455. (in Russ.). eLIBRARY ID: 38564758

19. Balaboshka K. B., Khadzkou Y. K., Kubrakov K. M., Abdulin Z. N. Efficacy of integrated approach to total knee replacement perioperative management. Novosti Khirurgii. 2020; 28 (1): 53–61. (in Russ.). DOI: 10.18484/2305-0047.2020.1.53.

20. Burkey D. R. Regional anesthesia and pain management. Philadelphia: Saunders/Elsevier; 2009: 403–414. ISBN13- 9781416033448.

21. Doleman B., Leonardi- Bee J., Heinink T. P., Boyd- Carson H., Carrick L., Mandalia R., Lund J. N., et al. Pre-emptive and preventive NSAIDs for postoperative pain in adults undergoing all types of surgery. Cochrane Database Syst Rev. 2021; 6 (6): CD012978. DOI: 10.1002/14651858.CD012978.pub2. PMID: 34125958

22. Helander E. M., Menard B. L., Harmon C. M., Homra B. K., Allain A. V., Bordelon G. J., Wyche M. Q., et al. Multimodal analgesia, current concepts, and acute pain considerations. Curr Pain Headache Rep. 2017; 21 (1): 3. DOI: 10.1007/s11916-017-0607-y. PMID: 28132136.

23. Ozlem S., Banu C., Saracoglu K. T. The effect of single-dose preemptive intravenous ibuprofen on the intraoperative hemodynamic parameters, recovery characteristics, and acute pain after laparoscopic cholecystectomy: a randomized double- blind, placebo- controlled clinical trial. International Journal of Anesthetics and Anesthesiology. 2020; 7 (4). Open access. DOI: 10.23937/2377-4630/1410118

24. Pýnar H. U., Karaca Ö, Karakoç F., Doða R. Effects of addition of preoperative intravenous ibuprofen to pregabalin on postoperative pain in posterior lumbar interbody fusion surgery. Pain Research and Management. 2017. Open access. DOI: 10.1155/2017/1030491.

25. Selçuk I., Selçuk N., Can M. F., Yilmaz A. T. Karotis arter stenozunda cerrahi endarterektomi ile endovasküler stent implantasyonunun orta ve geç dönemde morbidite ve mortalite sonuçlarýnýn karþýlaþtýrýlmasý. Göðüs Kalp Damar Anestezi ve Yoðun Bakým Derneði Dergisi. 2021; 27 (2): 155–160. (in Turk.). Comparison of mid-, and lateterm morbidity and mortality results of surgical endarterectomy versus endovascular stent implantation in carotid artery stenosis. Journal of Cardio- Vascular- Thoracic Anaesthesia and Intensive Care Society. 2021; 27 (2): 155–160. DOI: 10.5222/GKDAD.2021.63496.

26. Sadykova T. T., Zhalgasbaev S. K. The pre-emptive effect of intravenous ibuprofen on reducing the need for opioids in oncogynecology. Personal experience. Innovation. Science. Education. / Innovatsii. Nauka. Obrazovaniye. 2021; 43: 846–852. (in Russ.). eLIBRARY ID: 47235514.

27. Drożdżal S., Lechowicz K, Szostak B., Rosik J., Kotfis K., Machoy- Mokrzyńska A., Białecka M., et al. Kidney damage from nonsteroidal anti-inflammatory drugs — myth or truth? Review of selected literature. Pharmacol Res Perspect. 2021; 9 (4): e00817. DOI: 10.1002/prp2.817. PMID: 34310861.

28. NSAIDs and acute kidney injury. URL: https://www.medsafe.govt.nz/profs/PUArticles/June2013NSAIDS.htm (дата обращения/accessed: 10.07.2023).

29. Schafer A. I. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995; 35 (3): 209–219. DOI: 10.1002/j.1552-4604.1995.tb04050.x. PMID: 7608308